The treatment landscape of generalised myasthenia gravis, a prototypic antibody-mediated disorder of the neuromuscular junction, has considerably evolved in the past 8 years.1 The approval of targeted ...

When an axolotl loses a limb to a hungry predator, it sprouts a structurally sound replacement, rebuilding flesh, bone, and ...

If your immune system overreacts to pollen or other allergens, a diet rich in compounds that boost immune health and reduce ...

A 2026 structured overview of VidaCalm's 18-ingredient hearing support formula, ingredient research context, safety ...

A Peak Health Research informational report on OsteoShield's bone density support formulation, Aquamin marine mineral complex, Palm-Collagen blend, zombie cell inflammation research context, ...

Objective Macrophages and kidney cell pyroptosis/ferroptosis could play an important role in the pathogenesis of lupus ...

First patient dosed in Opti-GAIN, a first-in-human Phase I/II clinical trial of CTx001 in Geographic Atrophy secondary to AMD CTx001 is an investigational AAV-based gene therapy designed to deliver ...

Immunoglobulin A (IgA) nephropathy results from the accumulation of IgA-containing immune complexes (IgA-ICs) and aberrant IgA antibodies in the glomerular mesangium. Now, researchers have found that ...

The ventral tegmental area (VTA) is a key site for opioid actions, and emerging evidence suggests that pain states and opioid experience both induce transcriptional, molecular, and circuit adaptations ...

Accurate measurement of HMGB-1, neopterin and sIL-2R supports reliable assessment of immune activation across clinical and ...